Mercury Bio and Meta-Flux Announce Strategic Collaboration to Advance Large-Molecule Therapeutics for Parkinson's and Alzheimer's Diseases
PR Newswire —
SANTA FE, N.M. and CAMBRIDGE, Mass., Dec. 19, 2025 /PRNewswire/ -- Mercury Bio, a biotechnology company advancing large-molecule therapeutics for neurodegenerative disease, and Meta-Flux, an AI-powered disease simulation company, have announced a strategic collaboration to accelerate the...